[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=NEO #%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]

NEO — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

13.26

Margin Of Safety %

Put/Call OI Ratio

0.04

EPS Next Q Diff

0.08

EPS Last/This Y

1.02

EPS This/Next Y

0.16

Price

19.33

Target Price

19.72

Analyst Recom

1.67

Performance Q

36.41

Upside

-172.4%

Beta

1.78

Ticker: NEO

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-08-28	NEO	18.04	0.04	0.01	14300
2026-08-31	NEO	17.91	0.04	0.25	14583
2026-09-02	NEO	17.4	0.04	0.03	14620
2026-09-03	NEO	17.46	0.04	0.13	14627
2026-09-04	NEO	17.38	0.04	0.13	14632
2026-09-08	NEO	17.57	0.04	0.00	14665
2026-09-09	NEO	17.65	0.04	0.00	14710
2026-09-10	NEO	17.59	0.04	0.02	14699
2026-09-11	NEO	17.31	0.04	0.00	14702
2026-09-14	NEO	18.42	0.04	0.00	14716
2026-09-15	NEO	18.89	0.04	0.04	14694
2026-09-16	NEO	18.94	0.04	0.04	15135
2026-09-17	NEO	19.89	0.04	0.01	15342
2026-09-18	NEO	19.9	0.04	0.01	15662
2026-09-21	NEO	19.4	0.04	0.23	14813
2026-09-22	NEO	18.87	0.04	0.30	14778
2026-09-23	NEO	18.34	0.04	0.04	14773
2026-09-24	NEO	19.56	0.04	0.15	14770
2026-09-25	NEO	19.33	0.04	0.81	14797
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-08-28	NEO	18.03	73.3	-	0.18
2026-08-31	NEO	17.92	73.3	-	0.18
2026-09-01	NEO	17.44	73.3	-	0.18
2026-09-02	NEO	17.40	73.3	-	0.18
2026-09-03	NEO	17.42	73.3	-	0.18
2026-09-04	NEO	17.37	73.3	-	0.18
2026-09-08	NEO	17.58	73.3	-	0.18
2026-09-09	NEO	17.64	73.3	-	0.18
2026-09-10	NEO	17.57	73.3	-	0.18
2026-09-11	NEO	17.32	73.3	-	0.18
2026-09-14	NEO	18.42	73.3	-	0.18
2026-09-15	NEO	18.89	73.3	-	0.18
2026-09-16	NEO	18.89	73.3	-	0.18
2026-09-17	NEO	19.87	78.8	-	0.18
2026-09-18	NEO	19.90	78.8	-	0.18
2026-09-21	NEO	19.39	78.8	-	0.18
2026-09-22	NEO	18.89	78.8	-	0.18
2026-09-23	NEO	18.36	78.8	-	0.18
2026-09-24	NEO	19.57	78.8	-	0.18
2026-09-25	NEO	19.33	78.8	-	0.18
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-08-28	NEO	-1.25	9.84	12.60
2026-08-31	NEO	-1.25	9.80	12.60
2026-09-01	NEO	-1.25	9.80	12.60
2026-09-02	NEO	-1.25	9.80	12.60
2026-09-03	NEO	-1.23	9.80	12.60
2026-09-04	NEO	-1.23	9.80	12.60
2026-09-08	NEO	-1.23	9.77	12.60
2026-09-09	NEO	-1.23	9.77	12.60
2026-09-10	NEO	-1.23	9.77	12.60
2026-09-11	NEO	-1.23	9.77	12.51
2026-09-14	NEO	-1.23	9.57	12.51
2026-09-15	NEO	-1.23	9.57	12.51
2026-09-16	NEO	-1.23	9.57	12.51
2026-09-17	NEO	-1.23	9.57	12.51
2026-09-18	NEO	-1.23	9.57	12.51
2026-09-21	NEO	-1.23	9.57	12.51
2026-09-23	NEO	-1.23	9.57	12.51
2026-09-24	NEO	-1.23	9.57	12.51
2026-09-25	NEO	-1.23	9.57	13.26
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=NEO 589 360 ]

Last Quarter Act. EPS

-0.01

Avg. EPS Est. Current Quarter

0.05

Avg. EPS Est. Next Quarter

0.07

Insider Transactions

-1.23

Institutional Transactions

9.57

Beta

1.78

Average Sales Estimate Current Quarter

205

Average Sales Estimate Next Quarter

209

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

64.7

Max Drawdown 5-Year %

-90.1

Target Price

19.72

P/E

Forward P/E

57.16

PEG

P/S

3.24

P/B

3.15

P/Free Cash Flow

EPS

-0.4

Average EPS Est. Cur. Y

0.18

EPS Next Y. (Est.)

0.34

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-6.77

Relative Volume

0.6

Return on Equity vs Sector %

-32.9

Return on Equity vs Industry %

-18.1

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

[iframe https://widget.finnhub.io/widgets/recommendation?symbol=NEO 589 450 ]

[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=NEO 589 450 ]

◆ NEO Healthcare

$19.33

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

20/20

Pullback

8/25

Volume

9/15

Valuation

6/20

TP/AR

3/10

Options

7/10

RSI

61.1

Range 1M

83.9%

Sup Dist

3.1%

🚀

Momentum Growth

Ride accelerating trends

N/A

WATCH

Momentum

13/25

Growth

27/30

Estimates

4/20

Inst/Vol

9/15

Options

5/10

EPS Yr

52.3%

EPS NY

85.1%

52W%

95.7%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🔴 SELL -26.9% upside

Quality

6/30

Valuation

2/30

Growth

21/25

Stability

7/10

LT Trend

4/5

Upside

-26.9%

Quality

NEO — P/E HistoricalDiagnostics & Research

NeoGenomics, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 2500

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. The company was founded in 2001 and is headquartered in Fort Myers, Florida.

[News_NEO _Stock]

stock quote shares NEO – NeoGenomics, Inc. Stock Price stock today

news today NEO – NeoGenomics, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch NEO – NeoGenomics, Inc. yahoo finance google finance

stock history NEO – NeoGenomics, Inc. invest stock market

stock prices NEO premarket after hours

ticker NEO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: NEO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y